Triple negative breast cancer (TNBC) has been proved as a biologically separate entity, having special prognosis and behavior as it lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Here, ERBB2 is linked to triple-negative breast carcinoma.